{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Stanford&page=3&state=California", "query": { "state": "California", "city": "Stanford", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 6680, "total_pages": 668, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Stanford&page=4&state=California&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Stanford&page=2&state=California&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-05T08:32:48.214Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00709280", "title": "Infant Study of Inhaled Saline in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "7% Hypertonic Saline (HS)", "type": "DRUG" }, { "name": "0.9% Isotonic Saline (IS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CF Therapeutics Development Network Coordinating Center", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Months", "maximum_age": "59 Months", "sex": "ALL", "summary": "4 Months to 59 Months" }, "enrollment_count": 321, "start_date": "2009-04", "completion_date": "2011-11", "has_results": false, "last_update_posted_date": "2013-02-12", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 28, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Palo Alto, California + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00709280" }, { "nct_id": "NCT02796196", "title": "Prescribed Physical Activity in Improving Sleep and Physical Performance in Patients Undergoing Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cell Transplantation" ], "interventions": [ { "name": "Medical Chart Review", "type": "OTHER" }, { "name": "Monitoring Device", "type": "DEVICE" }, { "name": "Physical Therapy", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "DEVICE", "PROCEDURE" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 75, "start_date": "2016-05", "completion_date": "2017-03-01", "has_results": false, "last_update_posted_date": "2018-11-29", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02796196" }, { "nct_id": "NCT00005603", "title": "Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Leukemia" ], "interventions": [ { "name": "asparaginase", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "daunorubicin hydrochloride", "type": "DRUG" }, { "name": "dexamethasone", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "mercaptopurine", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "thioguanine", "type": "DRUG" }, { "name": "vincristine sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 276, "start_date": "2000-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-02-20", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 20, "location_summary": "Los Angeles, California • Palo Alto, California • San Francisco, California + 16 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005603" }, { "nct_id": "NCT01816802", "title": "Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Infertility" ], "interventions": [ { "name": "In-vitro fertilization using Eeva", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Progyny, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 1200, "start_date": "2013-02", "completion_date": "2015-06", "has_results": false, "last_update_posted_date": "2015-03-26", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 12, "location_summary": "Encino, California • Palo Alto, California • Redondo Beach, California + 8 more", "locations": [ { "city": "Encino", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Redondo Beach", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Farmington", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT01816802" }, { "nct_id": "NCT04987229", "title": "Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar I Disorder", "Schizophrenia" ], "interventions": [ { "name": "OLZ/SAM", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 236, "start_date": "2021-10-22", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-08-14", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 15, "location_summary": "Dothan, Alabama • Little Rock, Arkansas • Stanford, California + 12 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Stanford", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04987229" }, { "nct_id": "NCT07246902", "title": "Mobilization and Outcomes After Venous Closure", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Venous Vascular Closure", "Electrophysiology Study" ], "interventions": [ { "name": "MYNX CONTROLTM VENOUS Vascular Closure Device", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cordis US Corp.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 339, "start_date": "2025-11-24", "completion_date": "2026-08-26", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 9, "location_summary": "Los Angeles, California • Palo Alto, California • Littleton, Colorado + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Littleton", "state": "Colorado" }, { "city": "Orlando", "state": "Florida" }, { "city": "Glenview", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07246902" }, { "nct_id": "NCT02949401", "title": "Stress Inoculation Through Virtual Reality in the Pediatric Electrophysiology Laboratory", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress, Psychological", "Stress, Physiological", "Anxiety", "Pain Perception" ], "interventions": [ { "name": "Use of Virtual Reality App", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "10 Years to 20 Years" }, "enrollment_count": 40, "start_date": "2017-01", "completion_date": "2018-04-16", "has_results": false, "last_update_posted_date": "2019-03-20", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02949401" }, { "nct_id": "NCT04422912", "title": "A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pemphigus Vulgaris" ], "interventions": [ { "name": "DSG3-CAART", "type": "BIOLOGICAL" }, { "name": "CABA-201", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Cabaletta Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2020-09-29", "completion_date": "2029-01", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 13, "location_summary": "Redwood City, California • Sacramento, California • New Haven, Connecticut + 9 more", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT04422912" }, { "nct_id": "NCT04599881", "title": "A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Recessive Dystrophic Epidermolysis Bullosa" ], "interventions": [ { "name": "PTR-01", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phoenix Tissue Repair, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 6, "start_date": "2020-10-15", "completion_date": "2021-09-01", "has_results": false, "last_update_posted_date": "2021-09-16", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 2, "location_summary": "Redwood City, California • Aurora, Colorado", "locations": [ { "city": "Redwood City", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04599881" }, { "nct_id": "NCT03941379", "title": "A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Choroidal Melanoma", "Indeterminate Lesions of Eye" ], "interventions": [], "intervention_types": [], "sponsor": "Aura Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 63, "start_date": "2019-03-27", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-11-05T08:32:48.214Z", "location_count": 16, "location_summary": "Tucson, Arizona • Los Angeles, California • Palo Alto, California + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03941379" } ] }